WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: DELIGASE

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on DELIGASE

Proof of use for DELIGASE

We do not have any records of a proof of use for DELIGASE at this moment.

Click here to add a proof of use for DELIGASE

Possible trademark infringements of DELIGASE

Basic Information about DELIGASE

Serial Number
88855023
Filing Date
31 Mar 2020
Registration Number
6412399
Registration Date
06 Jul 2021
Mark Drawing Code
4

Classifications

Declare the trademark use of DELIGASE on the blockchain with WikiTrademarks.io.

First use of DELIGASE anywhere
DELIGASE was first used on 16 Jan 2020 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns DELIGASE?

1. Nurix Therapeutics, Inc. San Francisco CA

2. Nurix Therapeutics, Inc. San Francisco CA

3. Nurix Therapeutics, Inc. San Francisco CA

Correspondent

Lisa M. Martens
12275 EL CAMINO REAL, SUITE 200
SAN DIEGO CA 92130

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on DELIGASE